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Summary
We recently reported three truncating mutations of the
cytochrome P4501B1 gene (CYP1B1) in five families
with primary congenital glaucoma (PCG) linked to the
GLC3A locus on chromosome 2p21. This could be the
first direct evidence supporting the hypothesis that mem-
bers of the cytochrome P450 superfamily may control
the processes of growth and differentiation. We present
a comprehensive sequence analysis of the translated
regions of the CYP1B1 gene in 22 PCG families and 100
randomly selected normal individuals. Sixteenmutations
and six polymorphisms were identified, illustrating an
extensive allelic heterogeneity. The positions affected by
these changes were evaluated by building a three-di-
mensional homology model of the conserved C-terminal
half of CYP1B1. These mutations may interfere with
heme incorporation, by affecting the hinge region and/
or the conserved core structures (CCS) that determine
the proper folding and heme-binding ability of P450
molecules. In contrast, all polymorphic sites were poorly
conserved and located outside the CCS. Northern hy-
bridization analysis showed strong expression of
CYP1B1 in the anterior uveal tract, which is involved
in secretion of the aqueous humor and in regulation of
outflow facility, processes that could contribute to the
elevated intraocular pressure characteristic of PCG.
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Introduction
Severe primary congenital glaucoma (PCG) manifests it-
self during the neonatal or infantile period. The disease
is characterized by high intraocular pressure (IOP),
which, if uncontrolled, leads to optic-nerve damage and
permanent loss of vision (De Luise and Anderson 1983).
PCG is likely to be due to maldevelopment of the an-
terior chamber angle of the eye, thus interfering with
the aqueous-humor outflow (Allen et al. 1955; Barkan
1955; Maumenee 1958; Kupfer and Kaiser-Kupfer
1979; Anderson 1981). The resulting increase in IOP
produces ocular enlargement (buphthalmos), corneal
edema, and progressive optic-nerve cupping. PCG has a
higher incidence in Gypsies (1:1,250) and in the Middle
East (1:2,500) as compared with that in Western soci-
eties (1:5,000–1:22,000 births) (Francois 1980; Jaffar
1988; Gencik 1989). An autosomal recessive pattern of
inheritance is well documented (Francois 1980; Gencik
1989; Turacli et al. 1992). Families presenting with af-
fected individuals in successive generations have raised
the possibility that a pseudodominant form of the disease
may also exist. This may be due, however, to the mar-
riage of homozygous and heterozygous individuals (Sto-
ilov et al. 1997).
Recently, we reported the identification of three trun-
cating mutations in the human cytochrome P4501B1
gene (CYP1B1 [MIM 601771]) in five families with PCG
linked to locus GLC3A (MIM 231300) on chromosome
2p21 (Sarfarazi et al. 1995; Akarsu et al. 1996; Stoilov
et al. 1997). It has long been speculated that members
of the cytochrome P450 superfamily may be directly
involved in regulation of the processes of growth and
differentiation (Nebert 1990, 1991). Therefore, our find-
ing could be the first direct confirmation of this hy-
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Figure 1 Pedigrees of the 22 PCG families in the present study. CYP1B1 mutant alleles segregating in each family are defined in terms
of the one-letter code used in table 1. wt  Wild-type allele. Absence of genotype data indicates that a DNA sample from that individual was
not available for analysis. Pedigrees reported elsewhere are denoted by an asterisk (*).
pothesis. Herein, we present a comprehensive list of mu-
tations and polymorphic sites identified by direct
sequencing of the translated regions ofCYP1B1 in mem-
bers of 22 PCG families and 100 randomly selected nor-
mal individuals (50 British and 50 Turkish). The posi-
tions affected by these changes were evaluated with the
assistance of a three-dimensional model of the conserved
C-terminal half of CYP1B1 (Graham-Lorence and Pe-
terson 1996), which was build by homology modeling.
Subjects and Methods
Subjects
Twenty-two PCG families (fig. 1) from Turkey, the
United States, Canada, and the United Kingdom were
ascertained (Barsoum-Homsy and Chevrette 1986; Tur-
acli et al. 1992; Sarfarazi et al. 1995; Akarsu et al. 1996).
The affected individuals included in this study had an
aggressive form of glaucoma with an early onset (at age
0–3 years), manifested by symptoms of increased IOP
and corneal edema, including excessive tearing, photo-
phobia, buphthalmos, and cloudy cornea. Optic-nerve
cupping and ruptures of Descmet’s membrane were de-
termined, where possible. Individuals presenting with
other associated ocular or systemic anomalies were ex-
cluded. Therefore, the type of glaucoma discussed in the
present article represents isolated congenital glaucoma,
according to the Shaffer and Weiss (1970) classification,
and isolated trabeculodysgenesis, according to (Hoskins
Table 1
PCG Mutations in CYP1B1
Code Exon DNA Change Predicted Effect Location
Amino Acid
Deleted
Restriction
Site PCG Families
No. (%) of
PCG Chro-
mosomes
( )n  28 Ethnic Origin Reference
a 2 G517rC Trp57rCys Hinge region ) ) 1004 1 (3.57) Hispanic Present study
b 2 G528rA Gly61rGlu Hinge region ) TaqI 16, 18, 21, 24 5 (17.85%) Turkish Present study
c 2 847insT Frameshift ) 377 XhoI 13 1 (3.57) Turkish Present study
d 2 G1187rT Glu281rstop ) 262 ) 16 1 (3.57) Turkish Present study
e 2 1209insC Frameshift ) 254 ) 10, 11 1 (3.57) Turkish Stoilov et al. (1997)
f 3 Large deletion Splicing error ) ) ) 15 1 (3.57) Turkish Stoilov et al. (1997)
g 3 1410del13 Frameshift ) 189 XhoI 17, 26 2 (7.14%) Turkish Stoilov et al. (1997)
h 3 G1439rT Gly365rTrp Helix J ) ) 1007 1 (3.57) U.S. Present study
i 3 C1482rT Pro379rLeu Helix K ) ) 19 1 (3.57) Turkish Present study
j 3 G1505rA Glu387rLys Helix K ) ) 518, 520 2 (7.14%) Hispanic, French Canadian Present study
k 3 G1515rA Arg390rHis Helix K ) CfoI 4160 1 (3.57) Pakistani Present study
l 3 1546dup10 Frameshift ) 140 NlaIII 3, 19, 24, 1004, 4182 5 (17.86%) U.S., British, Turkish Present study
m 3 C1656rT Pro437rLeu Meander ) ) 25 1 (3.57) Turkish Present study
n 3 G1691del Frameshift ) 95 ) 518 1 (3.57) Hispanic Present study
o 3 C1751rT Arg469rTrp Heme binding ) AciI 18, 27, 29, 4182 4 (14.29%) British, Turkish Present study
p 3 1749dup27 Frameshift ) 76 BfaI 33 1 (3.57) Turkish Present study
Note.—Restriction assays for some of these mutations are also presented in figure 7.
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Figure 2 Observed sequence changes in CYP1B1. The translated regions are boxed by the thicker lines; and the conserved regions are
depicted as blackened. Mutations that are predicted to truncate the open reading frame are indicated by the blackened downward-pointing
arrows, whereas the missense mutations are indicated by unblackened downward-pointing arrows. All mutations are defined in terms of the
one-letter code used in table 1. Polymorphic positions are indicated by unblackened upward-pointing arrows. The horizontal line belowmutation
“f” denotes a splicing event.
Figure 3 Multiple sequence alignment for 22 different members of the cytochrome P450 superfamily. Conserved residues affected by
mutations are indicated by boldface letters. Single-letter code is used to denote the mutations (boldface, underlined, and indicated by the larger
arrows) and the polymorphic sites. The invariant cysteine residue in the heme-binding region is denoted by an asterisk (*).
et al.’s (1984) anatomic classification of developmental
glaucomas. Members of these families have identified
themselves as German American (family PCG-1007),
Hispanic (families PCG-518 and PCG-1004), FrenchCa-
nadian (family PCG-520), British (family PCG-4182),
Pakistani (family PCG-4160), and Turkish (families
PCG-3–PCG-31). All subjects provided informed con-
sent prior being included in this study.
Mutation Screening
Three primer sets were used to amplify the translated
regions of CYP1B1 from genomic DNA: set 1 (1F, 5′-
tctccagagagtcagctccg-3′; and 1R, 5′-gggtcgtcgtggctgtag-
3′ [786 bp]); set 2 (2F, 5′-atggctttcggccactact-3′; and 2R,
5′-gatcttggttttgaggggtg-3′ [787 bp]); and set 3 (3F, 5′-
tcccagaaatattaatttagtcactg-3′; and 3R, 5′-tatggagcacacct-
cacctg-3′ [885 bp]). PCR amplifications were performed
in a 40-ml volume containing 1.0 ml of 20 mM stock
solution for each primer oligo, 100 ng of genomic DNA,
1 U of AmpliTaq polymerase (Perkin-Elmer), 0.1 mM
of each dNTP, 1.5–2.0 mM MgCl2, 50 mM KCl, and
10 mM Tris-HCL (pH 9.3), by means of 35 cycles of
amplification, each consisting of 30 s denaturation at
94C, 30 s annealing at 56C, and 1 min extension at
72C. Sets 1 and 2 were amplified in the presence of 1.5
mM MgCl2 and 10% dimethyl sulfoxide (Sigma); and
set 3 was amplified in the presence of 2.0 mM MgCl2.
Dye terminator-cycle sequencing with AmpliTaq DNA
polymerase FS (Perkin-Elmer) was performed according
to the protocol supplied by the manufacturer. Analysis
of the sequencing reactions was performed on an ABI-
377 automated DNA Sequencer (Perkin-Elmer). Restric-
tion endonucleases were purchased from Gibco BRL (in
the case of CfoI, TaqI, and XhoI) or New England Bio-
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Figure 4 Sequence alignment/structure of CYP1B1, CYP102 (BM-P) and CYP108 (TERP), as generated by ProMod. Helical regions are
boxed, and the strand regions are underlined. The invariant residues Glu387, Arg390, and Cys470 are indicated by arrows.
labs (in the case of AciI), and assays were performed as
recommended by the supplier.
Analysis of the CYP1B1 Primary Structure by
Comparative Sequence Alignment
The amino acid sequences of 22 cytochrome P450
proteins belonging to CYP families 1–5, 7, 11, 17, and
21 were obtained from SwissProt and GenBank (Nelson
et al. 1993). Computer-assisted sequence alignment was
performed with the pattern-induced multi-sequence
alignment program (PIMA) (Smith and Smith 1992; the
program is available at http://dot.imgen.bcm.tmc.edu:
9331/multi-align/multi-align.html).
Construction of a Three-Dimensional Model of the
Conserved C-Terminal Half of the CYP1B1 Gene by
Homology Modeling
A three-dimensional model of the conserved C-ter-
minal part of CYP1B1 was constructed by homology
modeling with the assistance of the protein-modeling
tool ProMod (Peitsch 1996). There are two reasons to
expect that this approach could produce a realisticmodel
for the C-terminal part of the CYP1B1 protein. First,
three-dimensional models based on crystallization and
structural-resolution studies of several soluble bacterial
P450s are available and can be used as templates (Poulos
et al. 1987; Ravichandran et al. 1993; Hasemann et al.
1994). Second, all cytochrome P450 molecules share a
set of conserved structural elements. Included in these
structures are four helix bundles (helices D, I, and L and
the antiparallel helix E), helices J and K, b-sheets 1 and
2, the heme-binding region, and the “meander” region
just N-terminal of the heme-binding domain. Most of
these regions are located at the C-terminal half of the
molecule and are expected to be involved in the heme-
binding and proper folding of the molecule (Graham-
Lorence and Peterson 1996). The modeling was per-
formed as follows: First, the complete protein sequence
of CYP1B1 was screened against the ExPdb structure
database (derived from the Brookhaven Protein Data
Bank), in order to identify a template structure appro-
priate for modeling. From a series of templates, we se-
lected the three-dimensional models for CYP102
(P450BM-P bacterial fatty acid monooxygenase from
Bacillus magaterium) and CYP108 (P450TERP cata-
lyzes the hydroxilation of a-terpineol), because, first,
both of them were based on a crystallographic analysis,
and, second, CYP102 is considered to be the best model
for eukaryotic P450s. The multiple sequence/structure
alignment of CYP1B1, CYP102,, and CYP108 gener-
ated during the first attempt and the ProMod command
files were resubmitted for refinement of the primary
model, by energy minimization with CHARMM(Peitsch
1996). No manual editing of this alignment was made,
because the landmark residues Glu387, Arg390, and
Cys470, which are absolutely invariant among all mem-
bers of the cytochrome P450 family, were properly
aligned. Also, the location of different helices, strands,
and loops was overlapping with CYP1B1 secondary
structure, as predicted by the profile-fed neural-network
system (Rost and Sander 1993), on the basis of sequence
alignment of 84 different cytochrome P450s (data not
shown).
Expression of the Cytochrome CYP1B1 Gene in
Human Ocular and Nonocular Tissues
Expression of the CYP1B1 gene in human ocular and
nonocular tissues was studied by northern hybridization.
Total RNA extracted from ocular tissues of a pair of
eyes from a 55-year-old donor (cadaver) and from a
human cell line established from nonpigmented cilliary
epithelium (Martin-Vasallo et al. 1989) was size frac-
tionated by electrophoresis on denaturing 1% agarose-
formaldehyde gels and was transferred to a Nytran filter.
Radiolabeled probe was prepared from a 1,631-bp PCR
fragment amplified from cDNA (GenBank accession
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Figure 5 Three-dimensional model of the conserved C-terminal of the CYP1B1 protein. The a helices are indicated by capital letters and
are red; b strands are yellow; and random coils are gray. The side chains of the amino acid residues affected by mutations are blue. The side
chains of the polymorphic residues are green. The invariant Cys470 also is red.
number V03600) and containing the complete coding
sequence of the CYP1B1 gene. Expression of this gene
in nonocular tissues was studied by use of the same
probe and a premade blot (Clontech) containing
poly(A)mRNA (2 mg/lane) from heart, brain, placenta,
lung, liver, skeletal muscle, kidney, and pancreas.
Results
CYP1B1 Mutations
Sequencing analysis of the CYP1B1 translated regions
in 22 PCG families resulted in identification of 16 mu-
tations, 13 of which are novel and 3 of which have been
described elsewhere (table 1 and fig. 2; Stoilov et al.
1997). Eight (50%) of these mutations were predicted
to truncate the CYP1B1 open reading frame; they in-
clude one nonsense mutation (Glu281rStop), six frame-
shift mutations (847insT, 1209insC, 1410del13,
1546dup10, 1691delG, and 1749dup27), and one large
deletion. We also detected eight missense mutations:
Trp57rCys, Gly61rGlu, Gly365rTrp, Pro379rLeu,
Glu387r Lys, Arg390rHis, Pro437rLeu, and
Arg469rTrp. All of the mutations described above seg-
regated with the disease phenotype in one or more PCG
families (fig. 1) and were not present in 200 chromo-
somes from randomly selected normal individuals. The
segregation of the mutantCYP1B1 alleles was consistent
with autosomal recessive inheritance of the disease in all
families investigated. An interesting instance was ob-
served in family 1007, in which the affected children
were homozygous for Gly365rTrp, whereas their
mother was heterozygous for the same mutation. The
father, however, after several rounds of sequencing, was
found to be homozygous for the wild-type allele. In order
to assess the question of nonpaternity in this pedigree,
we also genotyped a total of 28 highly polymorphic
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Table 2
Polymorphisms in CYP1B1
LOCATION CODON
ALLELE
PREDICTED EFFECT
FREQUENCY IN 100 NORMAL INDIVIDUALS
(%)
Wild Typea New Wild Type/Wild Type Wild Type/New New/New
Intron 1 13b cctctctctg cctctttctg Not applicable 52 39 9
Exon 2 48 CGG GGG Arg48rGly 51 40 9
Exon 2 119 GCC TCC Ala119rSer 51 40 9
Exon 3 432 GTG CTG Val432rLeu 11 35 54
Exon 3 449 GAT GAC silent 10 39 51
Exon 3 453 AAC AGC Asn453rSer 59 34 7
a Alleles identical to the published cDNA sequence of CYP1B1 (Sutter et al. 1994) are indicated as wild type. These data are
based on analysis of 100 normal individuals, of which 50 were British and 50 were Turkish; the data from this two groups were
combined because they showed remarkably identical allelic frequencies.
b Upstream from ATG.
Figure 6 Northern analysis of CYP1B1 expression. A, Normal
ocular tissues: cilliary body (lane 1), cornea (lane 2), iris (lane 3),
retinal-pigment epithelium (lane 4), retina (lane 5), and nonpigmented
ciliary epithelial cell line (lane 6). Normal eyes were enucleated 2–3
h after death, and RNAwas extractedX24 h after death.B,Nonocular
tissues: heart (lane 1), brain (lane 2), placenta (lane 3), lung (lane 4),
liver (lane 5), skeletal muscle (lane 6), kidney (lane 7), and pancreas
(lane 8). In both A and B, the arrow on the right indicates the position
of the main transcript hybridized; its size is expected to be 5.1 kb.
RNA-molecular-weight markers are given on the left.
markers from the X and Y chromosomes and from the
autosomes. For the X-linked markers, the father and
daughter shared an identical haplotype, whereas, for the
Y-linked markers, the father and son shared another
haplotype. Also, none of the autosomal markers showed
any evidence of incompatibility in this pedigree. There-
fore, since we have found no evidence for nonpaternity,
and since the DNA samples used for the screening were
prepared from peripheral blood, we interpreted this as
a case of germinal mosaicism.
Evaluation of the Mutated Positions by Multiple
Sequence Alignment and Homology Modeling of
CYP1B1
Comparative amino acid sequence alignment of 22
different cytochrome P450 proteins revealed that all mis-
sense mutations had occurred at highly conserved po-
sitions (fig. 3). Six mutations (Gly61rGlu, Gly365rTrp,
Pro379rLeu, Glu387rLys, Arg390rHis, and
Pro437rLeu) affected positions conserved among at
least 19 of the 22 different cytochromes analyzed. Fur-
thermore, the position affected by Trp57rCys is occu-
pied by hydrophobic residue in 19 of 22 cytochrome
P450 sequences analyzed, with tryptophan presented in
all members of the CYP1B1 family. Finally, the
Arg469rTrp mutation affects a position that immedi-
ately precedes the invariant Cys470. It is interesting that,
in contrast to the other CYP families, in which this po-
sition is occupied by a neutral amino acid, in the CYP1
family it is occupied by either arginine or lysine, both
of which are basic and positively charged.
The fact that all missense mutations affected positions
conserved among different members of the P450 super-
family indicates that, most probably, they are interfering
with some universal properties of the cytochrome P450
molecule, such as heme binding. This was further sup-
ported when the mutated positions werematched to con-
served structural elements shared by cytochrome P450
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Table 3
Haplotype Analysis of PCG Chromosomes Harboring Recurrent Mutations Gly61rGlu and Arg469rTrp
NO. (SOURCE) OF MUTATIONSa
Gly61rGlu Arg469rTrp
16 (M) 18 (P) 21 (P) 21 (M) 24 (P) 18 (M) 27 (P) 27 (M) 29 (P/M) 4182 (P)
D2S1788 4 5 11 10 7 11 12 12 2 4
D2S1325 5 4 4 5 2 4 4 4 5 )
D2S177 5 2 3 7 3 5 4 5 9 5
D2S1346 5 4 4 8 4 5 4 4 5 6
D2S1348 ) 3 2 6 3 3 4 4 5 )
D2S1356 3 4 6 6 1 7 2 2 3 )
a M  maternal; and P  paternal.
molecules. Two mutations, Gly61rGlu and Trp57rCys
were predicted to affect the proline- and glycine-rich
region that follows the N-terminal transmembrane do-
main. This “hinge” region is characteristic of the mi-
crosomal cytochrome P450s. Its predicted function is to
permit flexibility in connection between the membrane-
spanning domain and the cytoplasmic portion of the
molecule (Yamazaki et al. 1993). Induced mutations in
the hinge region have previously been reported to in-
terfere with the proper folding and heme-binding prop-
erties of the cytochrome P450 molecules (Yamazaki et
al. 1993; Chen and Kemper 1996). The remaining six
missense mutations were located in the 5′ end of exon
3 and directly affected the elements of the conserved core
structures (CCS): helix J (Gly365rTrp), helix K
(Pro379rLeu, Glu387rLys, and Arg390rHis), the me-
ander region (Pro437rLeu), and the heme-binding re-
gion (Arg469rTrp) (figs. 4 and 5). The heme-binding
region is also predicted to be eliminated by every one
of the truncating mutations described above.
Polymorphisms in the CYP1B1 Gene
Sequence analysis of the translated regions in 50 Turk-
ish and 50 British normal unrelated individuals resulted
in the identification of six polymorphic sites (table 2).
These positions were characterized by a high degree of
variability (fig. 3) and mapped outside the CCS (fig. 5).
Analysis of CYP1B1 Expression
An abundant mRNA target for the CYP1B1 probe
was observed in the ciliary body and iris and in the
nonpigmented ciliary epithelial cell line (fig. 6). The
amounts of mRNA target in the cornea, retinal-pigment
epithelium, and retina were much lower. Elsewhere we
have demonstrated the presence of CYP1B1 mRNA in
the trabecular-meshwork cell line, by quantitative PCR
amplification (Stoilov et al. 1997). Relatively low con-
stitutive levels of CYP1B1mRNA were detected in most
of the nonocular tissues studied, with the kidneys dem-
onstrating relatively higher levels of expression. This
pattern of nonocular expression is in agreement with
results reported elsewhere (Sutter et al. 1994).
Discussion
CYP1B1 is the only knownmember of the cytochrome
P450 subfamily of CYP1B. The human gene, which, in
a previous study (Tang et al. 1996), had been mapped
to the 2p21-22 region, consists of three exons (one of
which is noncoding) and two introns (Tang et al. 1996;
Stoilov et al. 1997). Because of its map position,
CYP1B1 was considered as a candidate gene for PCG
(GLC3A), which, in a previous study, had been linked
to the 2p21 region (Sarfarazi et al. 1995). Recently, we
reported three truncating mutations, in the CYP1B1
gene, that segregated with the disease phenotype in five
PCG families (Stoilov et al. 1997). These data strongly
suggested that mutations affecting CYP1B1 are respon-
sible for the PCG phenotype that is associated with the
GLC3A locus.
This article has described the identification and char-
acterization of 22 allelic variants of the human CYP1B1
gene. Sixteen of these segregated with the disease phe-
notype in one or more PCG families and were not pres-
ent in 200 chromosomes from randomly selected normal
individuals. Since these mutations were predicted either
to truncate the protein or to substitute exclusively highly
conserved residues with an established functional im-
portance, they were considered to be disease-causing
mutations (table 1). Six allelic variants (1) showed no
relation to the disease phenotype in the affected families,
(2) were observed in the general population and (3) af-
fected exclusively poorly conserved positions. These
changes were considered to be naturally occurring pol-
ymorphisms (table 2).
Members of these 22 PCG families have identified
their ethnic origin as Turkish, British, French Canadian,
German American, Pakistani, or Hispanic. Recently,
linkage to locus GLC3A has been reported, both in fam-
ilies from Saudi Arabia (B. A. Bejjani and J. R. Lupski,
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personal communication) and in the Gypsy population
(Roms) of Slovakia (Plasilova et al. (1998)). Taken to-
gether, these data indicate that mutations in theCYP1B1
gene may be responsible for a substantial number of
PCG cases, both in the high-incidence regions of the
Near East and Middle East and in the relatively low-
incidence regions of Europe and North America. How-
ever, a much lower proportion of the PCG cases are also
caused by mutations in at least two other unknown
genes, one of which (i.e., the GLC3B locus) is known
to be located on 1p36 (Akarsu et al. 1996).
The 16 mutations identified in this study are part of
a diverse group of DNA rearrangements and include 8
missense mutations, 1 nonsense mutation, 6 frameshifts
(deletions, insertions, or duplications), and 1 large de-
letion. Eleven mutations (68.75%) were observed on a
single PCG-bearing chromosome. Five mutations
(Gly61rGlu, 1410del13, Glu387rLys, 1546dup10, and
Arg469rTrp) either were recurrent, in which case they
may have originated from a single ancestral mutation
event, or arose independently more than once. In the
Turkish population, association of both Gly61rGlu and
Arg469rTrp with at least three different alleles for the
closest flanking markers, D2S177 and D2S1346 (table
3), indicated that these mutations were most probably
introduced by several independent mutational events.
Segregation of the mutant CYP1B1 alleles was con-
sistent with the autosomal recessive inheritance of the
disease, in all the families studied. Two mutant alleles
were inherited by every affected individual. Their normal
siblings either had two normal alleles or were hetero-
zygous for a single mutant allele segregating in that par-
ticular family. The penetrance of the disease was 100%,
and no phenocopies were observed.
Currently, cDNAs for 1300 cytochrome P450 have
been cloned and sequenced (Nelson et al. 1993), and
three-dimensional models based on crystallization and
structural-resolution studies of several soluble bacterial
P450s also have become available (Poulos et al. 1987;
Ravichandran et al. 1993; Hasemann et al. 1994).
Therefore, we utilized these resources and evaluated the
effects of the observed mutations in the context of un-
derstanding the structure and function of the cyto-
chrome P450 molecule.
Truncating Mutations
Themutations predicted to truncate theCYP1B1 open
reading frame are expected to eliminate 79–377 amino
acids from the -COOH terminus of the CYP1B1 poly-
peptide. Therefore, if a stable protein is synthesized, then
every one of the mutant molecules would lack at least
the heme-binding region, which is essential for the func-
tion of the cytochrome P450 molecules. We therefore
expect that these mutations will result in functional null
alleles. Alternatively, these mutations may interfere with
RNA metabolism by the nonsense-mediated mRNA-de-
cay mechanism (Baserga and Benz 1988).
Missense Mutations
Trp57rCys.—The position affected by this mutation
is located in the hinge region. In CYP1B1 protein this
region has the sequence 51PPGPFAWP58. Substitution
of the proline residues in the corresponding segments of
CYP2C11 and CYP2C2 produced defective heme in-
corporation and reduced enzymatic activity (Yamazaki
et al. 1993; Chen and Kemper 1996). Trp57rCys affects
the position preceding the last proline residue. There is
a hydrophobic residue at this position in 19 of 22 CYP
sequences analyzed by us, with tryptophan being present
in all CYP1B1 molecules. It is possible that the substi-
tution of nonpolar and hydrophobic tryptophan by po-
lar cysteine interferes with the proper folding of the
CYP1B1molecule, in a manner similar to that suggested
for the flanking hydrophobic proline residues. Identifi-
cation of Trp57rCys confirms the importance of the
hinge region in the normal functioning of the cyto-
chrome P450 molecule, as has been suggested by earlier
studies. It also indicates, however, that proline residues
are probably not the sole determinants of the hinge
region.
Gly61rGlu.—This mutation (fig. 7B) is located 3
amino acids downstream from the last proline residue
of the hinge region as defined by Yamazaki et al. (1993).
Although both proline and glycine residues are found in
this region, Yamazaki et al. concluded that folding of
the P450 molecule seems to depend mainly on the pro-
line residues, because, first, they are more conserved,
and, second, their substitution results in a complete loss
of heme incorporation. However, no functional studies
on glycine mutants have been reported. Also, according
to multiple sequence alignments provided both in the
present article and in previous reports (Yamazaki et al.
1993; Chen and Kemper 1996), the glycine residue af-
fected by Gly61rGlu is one of the most highly conserved
positions in this region. It is, then, quite possible that
Gly61 is a functional part of the hinge region and acts
in a way similar to that described for the induced mu-
tants in this region.
Gly365rTrp and Pro379rLeu.—These two muta-
tions affect highly conserved positions marking the end
and beginning of helix J and helix K, respectively (fig.
5). Both glycine and proline are potential turns and helix
breakers frequently observed at the N- and C-termini of
a helical structures. Their substitution by a residue lack-
ing such properties would most probably affect the ori-
entation of helices J and K, both of which belong to the
CCS.
Arg390rHis and Glu387rLys.—These two residues
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Figure 7 Restriction-endonuclease assays for Arg469rTrp (A), Gly61rGlu (B), Arg390rHis (C), and 847insT (D). Sizes of the marker
bands (in nucleotides) are given on the left side of each panel, whereas allele sizes are given on the right side of each panel. Sizing was performed
with a 123-bp ladder (GibcoBRL). Restriction-endonuclease digestion was performed according to the manufacturer’s instructions, and the
samples were analyzed on 2% agarose gel. The genotypes are defined in terms of the one-letter code used in figure 1.
are located in the conserved helix K. They form the
consensus sequence GluXXArg, which is absolutely con-
served among all members of the cytochrome P450 su-
perfamily. Arg390 (fig. 4) and Glu387 (fig. 4) are one
helical turn apart and are predicted to form a salt bridge.
The parallel orientation of their side chains is more
transparent in the three-dimensional model (fig. 5). The
exceptional conservation of this motif indicates that it
is essential for the normal function of the P450molecule.
However, it is still unclear exactly what this function is.
Pro437rLeu.—This mutation is located in the me-
ander region (fig. 5; Graham-Lorence and Peterson
1996), which precedes the heme-binding region. This
mutation affects the first proline residue from the pro-
posed consensus sequence xPcxFxPEa (x any amino
acid; a  aromatic residue; c  charged residue; and 
 positively charged residue).
Arg469rTrp (fig. 7A).—The cysteine in the heme-
binding region (Cys470 in CYP1B1), which provides the
axial heme ligand, is absolutely conserved among mem-
bers of the cytochrome P450 superfamily (fig. 3). In the
three-dimensional model shown in figure 5, this residue
is colored red. The arginine affected by Arg469rTrp
immediately precedes this invariant Cys470. We ana-
lyzed 86 different P450 sequences and found no se-
quence in which the invariant cysteine is preceded by
tryptophan. It is possible that the large and rigid side
group of tryptophan interferes with the normal confor-
mation of the cysteine pocket, which contains a number
of highly conserved positions, including Phe463 (part of
the cysteine pocket in P450cam—5-exo-hydroxylase of
camphor), Gly466 (which initiates a hairpin turn) and
Arg468 (which interacts with the heme propionate
group).
In conclusion, our data indicate that mutations iden-
tified in this study most probably interfere with the
heme-binding ability of the CYP1B1 molecule, either by
deleting the heme-binding region or by affecting discrete
components of the hinge region and/or the CCS, which
are determinants for the proper folding and heme-bind-
ing ability of the cytochrome P450 molecules.
Expression of CYP1B1 in Ocular and Nonocular
Tissues
Previous studies detected CYP1B1 mRNA in most of
the nonocular tissues investigated (Sutter et al. 1994).
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Also, tumor-specific expression of CYP1B1 protein has
been reported recently (Murray et al. 1997). It has also
been demonstrated that the CYP1B1 promoter is con-
stitutively active (Wo et al. 1997). In the course of this
study the presence ofCYP1B1mRNA in different ocular
tissues was analyzed at the mRNA level by northern
hybridization (fig. 6). Strong signals were generated from
tissues representing the anterior uveal tract of the eye:
the cilliary body, the nonpigmented ciliary epithelium,
and the iris. These structures have highly specialized
functions, including accommodation, regulation of out-
flow facility, and formation of aqueous humor. CYP1B1
can influence these processes by participating in the me-
tabolism of regulatory molecules such as steroids and
derivatives of archidonic acid. Such molecules could be
synthesized locally or could delivered to the cilliary body
via the bloodstream. It has been shown that CYP1B1
can catalyze the 4-hydroxylation of 17b-estradiol (Hayes
et al. 1996). Unfortunately, apart from their importance
in the excretion of E1 and E2, the physiological role for
hydroxyestrogens remains unclear. Therefore, further
studies are required for an understanding both of the
true nature of substrates being metabolized by the
CYP1B1 gene and of their involvement in the overall
development of the eye.
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